According to the company, strong volume growth contributed by key products such as lansoprazole, tacrolimus, omeprazole Mg OTC apart from new launches of fondaparinux and antibiotics portfolio have also contributed to the rise in revenues in the US.
Shouguang Fukang Pharmaceutical Co., Ltd.
Trimethoprim|TMP|Omeprazole|Sulfamethoxazole|SMZ|Metformin HCl|Bromide compounds